ClinicalTrials.gov
public full text
Public Domain
Dosage Form Proportionality of Opicapone To-Be-Marketed Formulation
Single-centre, open-label, randomized, two-sequence, two-way crossover study. The study consisted of two consecutive single-dose treatment periods separated by a washout period of 10 to 14 days or more.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- metronidazol 5 mg/ml 100 ml perfusion intravenosa#296880
- Single Ascending Dose and Multiple Ascending Dose Study of Voriconazole Inhalation Powder in Healthy Adult Subjects#801257
- Bioavailability and Bioequivalence Study of Two Different Sources of Opicapone#994574
- A Phase 1 Trial of OPA-15406 Ointment in Healthy Adult Male Subjects#1058282
- Intra-anal Oxymetazoline in Healthy Adult Volunteers#1060004
Record · ID 827983
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive